We are live on ! Find out more
Alyeska Investment Group

Alyeska Investment Group Portfolio holdings

AUM $35.4B
1-Year Est. Return 33.54%
This Fund
S&P 500
This Quarter Est. Return
+6.71%
1 Year Est. Return
+33.54%
3 Year Est. Return
+101.08%
5 Year Est. Return
+102.29%
10 Year Est. Return
+544.32%
AUM
$12.3B
AUM Growth
+$229M
Cap. Flow
-$342M
Cap. Flow %
-2.78%
Top 10 Hldgs %
11.52%
Holding
627
New
166
Increased
116
Reduced
155
Closed
161

Sector Composition

Rank Sector Weight
1 Technology 14.15%
2 Healthcare 12.62%
3 Financials 12.54%
4 Industrials 12.05%
5 Consumer Discretionary 11.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CFRX
426
DELISTED
ContraFect Corporation
CFRX
$1.28M 0.01%
891
-89
-9% -$140K
AERI
427
DELISTED
Aerie Pharmaceuticals
AERI
$1.2M 0.01%
26,558
-78,070
-75% -$3.48M
XTLY
428
DELISTED
Xactly Corporation
XTLY
$1.19M 0.01%
+100,000
New +$1.19M
IMDZ
429
DELISTED
Immune Design Corp.
IMDZ
$1.13M 0.01%
165,545
-1,948
-1% -$11.3K
PTN
430
Palatin Technologies
PTN
$14M
$1.12M 0.01%
2,740
-33
-1% -$16.4K
UTI icon
431
Universal Technical Institute
UTI
$1.59B
$1.11M 0.01%
+322,423
New +$1.09M
STAG icon
432
STAG Industrial
STAG
$7.18B
$1.08M 0.01%
43,327
-18,361
-30% -$448K
VLRX
433
DELISTED
VALERITAS HOLDINGS INC
VLRX
$1.07M 0.01%
+7,500
New +$986K
VCEL icon
434
Vericel Corp
VCEL
$2.3B
$1.02M 0.01%
365,834
-321,891
-47% -$910K
VSAT icon
435
Viasat
VSAT
$11.1B
$957K 0.01%
15,000
-285,000
-95% -$18.7M
FCFS icon
436
FirstCash
FCFS
$8.76B
$935K 0.01%
+19,027
New +$846K
WWD icon
437
Woodward
WWD
$21.4B
$934K 0.01%
+13,747
New +$951K
LINC icon
438
Lincoln Educational Services
LINC
$1.3B
$928K 0.01%
330,328
+134,684
+69% +$289K
SYRE icon
439
Spyre Therapeutics
SYRE
$9.26B
$881K 0.01%
4,733
-55
-1% -$7.76K
AVEO
440
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
$872K 0.01%
+147,820
New +$1.07M
PETX
441
DELISTED
Aratana Therapeutics, Inc.
PETX
$795K 0.01%
+150,000
New +$1.01M
NVCN
442
DELISTED
Neovasc Inc.
NVCN
$788K 0.01%
21
WINT
443
CALL
DELISTED
Windtree Therapeutics Inc
WINT
$776K 0.01%
680,570
+502,000
+281% +$652K
CDTX
444
DELISTED
Cidara Therapeutics
CDTX
$771K 0.01%
4,942
-58
-1% -$10.2K
WRD
445
DELISTED
WildHorse Resource Development
WRD
$764K 0.01%
61,435
-238,565
-80% -$3.16M
OBSV
446
DELISTED
ObsEva SA Ordinary Shares
OBSV
$720K 0.01%
+69,152
New +$849K
AVGR
447
DELISTED
Avinger, Inc. Common Stock
AVGR
$619K 0.01%
3
TPVG icon
448
TriplePoint Venture Growth BDC
TPVG
$211M
$589K ﹤0.01%
42,258
-265,031
-86% -$3.5M
INNL
449
DELISTED
Innocoll Holdings plc Ordinary Shares
INNL
$548K ﹤0.01%
489,155
-348,471
-42% -$279K
WINT
450
DELISTED
Windtree Therapeutics Inc
WINT
$524K ﹤0.01%
459,364
-5,405
-1% -$7.02K

Similar funds

Alyeska Investment Group's Q1 2017 Portfolio in Review

As of Q1 2017, Alyeska Investment Group held 627 positions worth $12.3B, up 1.9% from $12.1B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Alyeska Investment Group's Q1 2017 filing shows 166 new, 116 increased, 155 reduced and 161 closed positions. Its largest new stake was Agilent Technologies: 2,378,330 shares worth $126M. The largest sale was Cisco, an estimated $141M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 15% a quarter earlier, followed by Healthcare and Financials.

  • Alyeska Investment Group's largest Q1 2017 buy was Agilent Technologies: 2,378,330 shares worth $126M.
  • Alyeska Investment Group added most to Palo Alto Networks in Q1 2017, an estimated $167M increase.
  • Alyeska Investment Group's biggest Q1 2017 reduction was Cisco, cutting an estimated $141M.
  • Alyeska Investment Group fully exited Stryker in Q1 2017, selling an estimated $134M.
  • Alyeska Investment Group's ten largest holdings make up 12% of its $12.3B portfolio in Q1 2017.
  • Alyeska Investment Group opened 166 new positions and closed 161 in Q1 2017.
  • Alyeska Investment Group's portfolio value rose 1.9% quarter-over-quarter to $12.3B.

Based on Alyeska Investment Group's 13F filing for Q1 2017, filed 15 May 2017.